Q1 2019 Roche Holding AG Corporate Sales Call Transcript
Ladies and gentlemen, welcome to the Roche's First Quarter Sales 2019 Audio Webcast and Conference Call. I'm Sherry, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Dr. Severin Schwan, CEO of the Roche Group. Please go ahead, sir.
Thank you, and welcome to our briefing on the quarter 1 sales. Going right into the presentation on Slide 6, you've seen that we started with strong sales growth into the current year, 10 percentage points up in Pharma, very much driven by the newly launched medicines; 1% in Diagnostics, so 8% sales growth for the group. You see on Slide 7, we keep a good momentum on a quarterly basis. And turning to Slide 8, we have now 27% of our Pharma sales coming from the more recently launched medicines. I mean, just to highlight 3 of them: OCREVUS, as you know, the best launch ever at Roche, continues to grow
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |